Park Medi World IPO opens Dec 10: Price band set at ₹154 to ₹162 per share; check lot size, objectives and more

Park Medi World IPO: Hospital chain Park Medi World has set a price band of ₹154 to ₹162 per share for its upcoming Initial Public Offering (IPO), valuing the company at roughly around ₹7,000 crore.

The ₹920 crore initial share sale will open for subscription on December 10 and end on December 12. The bidding for anchor investors will occur on December 9.

The IPO consists of a fresh issuance of equity shares worth ₹770 crore and an offer for sale (OFS) of ₹150 crore by promoter Ajit Gupta.

The company intends to use the fresh issue proceeds worth ₹380 crore for debt repayment and ₹60.5 crore for funding capital expenditure related to the development of a new hospital and the expansion of an existing hospital by its units, Park Medicity (NCR) and Blue Heavens, respectively.

A further ₹27.45 crore has been kept aside for the purchase of medical equipment by the company and its subsidiaries, Blue Heavens and Ratangiri. The remainder of funds will be used for unidentified inorganic acquisitions and corporate general purposes.

Park Medi World IPO: Lot size

A lot consists of 92 shares. The company said that 50% of the issue size has been reserved for qualified institutional buyers (QIBs), 35% for retail investors and 15% for non-institutional investors (NIIs).

The hospital chain will make its stock market debut on December 17.

About the company

Park Medi World is the second largest private hospital chain in North India with an aggregate bed capacity of 3,000 beds and the largest private hospital chain in terms of bed capacity in Haryana with 1,600 beds located in the state as of March 2025, according to a Crisil report.

Its network of hospitals comprises 13 multi-super speciality hospitals, with eight hospitals in Haryana, one hospital in New Delhi, three hospitals in Punjab and two hospitals in Rajasthan.

The company has expanded its total bed capacity from 2,550 beds as of March 31, 2023, to 3,250 beds as of September 30, 2025. It is further strengthening its network through a robust expansion pipeline across Ambala, Panchkula, Rohtak, New Delhi, Gorakhpur and Kanpur, according to the Red Herring Prospectus (RHP).

In Ambala, the company has acquired land adjacent to its existing hospital and is undertaking an expansion that will increase capacity from 250 beds to 450 beds, along with the addition of an onco-radiation facility. This project is expected to be completed by October 2027.

In Panchkula, construction is underway for a new 300-bed multi-super-speciality hospital, scheduled to become operational by April 2026. Meanwhile, in Rohtak, the company is developing a 250-bed hospital, which is expected to be ready for operations by December 2026.

Nuvama Wealth Management, CLSA India, DAM Capital Advisors and Intensive Fiscal Services are the book-running lead managers to the public issue.